Understanding why Black women receive different endometrial cancer treatments than White women
Multilevel determinants of racial disparities in receipt of guideline-concordant endometrial cancer treatment
This study is looking into why Black and White women with endometrial cancer often receive different treatments, and it aims to find ways to ensure that all women get the best care possible to improve their chances of survival.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10877033 on NIH RePORTER |
What this research studies
This research investigates the reasons behind the racial disparities in the treatment of endometrial cancer, particularly focusing on the differences in treatment received by Black and White women. It aims to identify various factors at multiple levels—such as healthcare systems, provider biases, and patient characteristics—that contribute to these disparities. By analyzing existing data and treatment guidelines, the research seeks to develop evidence-based interventions that can improve treatment equity. The ultimate goal is to enhance survival rates for all women diagnosed with endometrial cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research include Black women diagnosed with endometrial cancer who may be affected by disparities in treatment.
Not a fit: Patients who are not diagnosed with endometrial cancer or those who do not identify as Black may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more equitable treatment practices for endometrial cancer, improving survival rates for Black women.
How similar studies have performed: Previous research has highlighted racial disparities in cancer treatment, but this approach of examining multilevel determinants is relatively novel and untested.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Felix, Ashley S. — Ohio State University
- Study coordinator: Felix, Ashley S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.